Here is how it works:
– AmDen’s business development team works bilaterally between USA and Europe, and has more than 40 years of experience finding suitable pharmaceuticals for your portfolio.
– The AmDen database comprises over 4600 companies globally that have various products available for out licensing.
This extensive database provides AmDen a superb opportunity to select the most desirable compounds with the greatest payout to a licensing company.
How Does AmDen get paid?
– These services are provided on a finder’s fee basis with no cost to you unless there is a successful result. “Successful result” is defined as a signed contract between your company and the collaborating company.
– AmDen will present candidates to you for evaluation.
– Your approval is the determining factor as to whether we are to proceed with a project or continue the search for the right product. This part of the process is performed at no cost on your part.
– AmDen’s remuneration will only occur after a signed agreement between your company and the collaborating company. AmDen has no financial demand until we have found a product that is acceptable for you and agreed upon by the collaborating company.
– AmDen’s remuneration is determined by your product’s success in the market.
– We work through mutual contracts that ensure both parties a fair process.
– You have no financial obligation signing a contract with AmDen.
How and when does AmDen initiate the search for you?
-After signing the contract with AmDen, we will focus our search according to your specifications.
-Specifications can be in terms of medical specialty, type of drug, or market potential.
-AmDen would like the opportunity to help broaden your company’s portfolio with new products. If you have any questions, please give us a call.
Let us find products acceptable to you and the EU producer.